[1] 顾梅榴,朱秀国,徐先锋,等.2型糖尿病合并高血压患者的社区综合干预效果评价[J].现代预防医学,2014,41(4):651-657. [2] 左君丽,常桂丽,葛茜,等.高血压合并2型糖尿病患者血管功能算还高于单纯高血压患者[J].中华高血压杂志,2014,22(3):252-257. [3] Nishimura T,Nakatake Y,Konishi M,et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver[J].Biochim Biophys Acta,2000,1492(1):203-206. [4] 苏珂.2型糖尿病合并高血压患者血清脂联素水平与胰岛素抵抗的关系[J].中国临床康复,2006,36(10):18-20. [5] 赵琳琳,黄昆. 胰高血糖素样肽-1类似物药物的研究进展[J].中国现代应用药学,2010,27(1):16-20. [6] 谭碧峰,杨天伦,黄友良,等.替米沙坦与左旋氨氯地平治疗轻中度高血压以及对apelin-13及脂联素的影响[J].医学临床研究,2011,28(3):456-459. [7] 杨冉,王韫芳,张维.利拉鲁肽联合替米沙坦对早期糖尿病肾病患者血中TNF-α、IL-6及TGF-β1水平的影响[J].西部医学,2016,28(2):191-194. [8] 万杰君,罗彩娴,迟莲祥. 利拉鲁肽与脂联素关系的研究进展[J].医学综述,2014,20(2):307-309. [9] Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator[J].J Clin Invest,2005, 115(6): 1627-1635. [10] Cuevas-Ramos D, Almeda-Valdes P, Aguilar-Salinas CA, et al. The role of fibroblast growth factor 21 (FGF21) on energy balance, glucose and lipid metabolism[J].Curr Diabetes Rev,2009, 5(4): 216-220. [11] 沈珂珂,马豪莉,任丽君,等. 2型糖尿病患者血浆成纤维细胞生长因子-21水平的变化及意义[J].现代生物医学进展,2016,6(33):6526-6528.
2018, Vol. 35 
